Edwards Lifesciences Corporation (EW)

SEC filing

Edwards Lifesciences Corporation

EW · CIK 1099800

4 · Sep 11, 2026 · CVP, TAVR Lippis Daniel J. sold 619 shares at $87.51/share ($54,169); exercised options for 1,238 shares

CVP, TAVR Lippis Daniel J. sold 619 shares at $87.51/share ($54,169); exercised options for 1,238 shares

xslF345X06/doc4.xml

xslF345X06/doc4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).